Congenital adrenal hyperplasia. Plasma and urinary steroid conjugates in seven children with steroid 21-hydroxylase deficiency |
| |
Authors: | L. Viinikka O. Jänne J. Perheentupa R. Vihko |
| |
Affiliation: | 1. Department of Medical Chemistry and Children''s Hospital, University of Helsinki, Sf-00170 Helsinki 17 Finland;2. Department of Clinical Chemistry, University of Oulu, SF-90220 Oulu 22 Finland |
| |
Abstract: | Plasma neutral steroid sulphates and urinary neutral steroid sulphates and glucuronides from seven children (0.17–10.4 years) with steroid 21-hydroxylase deficiency were determined using gas-liquid chromatography and gas chromatography -mass spectrometry. Three of the patients were salt-losers. Large inter-individual variation in plasma concentration and urinary excretion of these compounds was observed. However, the group did have certain characteristic features. In plasma, the main compounds present were 3β-hydroxy-5-ene steroids. A progesterone metabolite, 5α-pregnane-3β,20α-diol, and a 17α-hydroxyprogesterone metabolite, 5β-pregnane-3α, 17α, 20α-triol, were present as sulphate conjugates and 3α, 17α-dihydroxy-5β-pregnan-20-one sulphate was identified for the first time in human peripheral plasma. In the urine, metabolites of 17α-hydroxyprogesterone were predominant and 5β-pregnane-3α, 17α,20α-triol, excreted mainly as a glucuronide, alone comprised about 50% of the neutral steroid excretion in these subjects. The next most abundant steroid was 3α,17α,20α-trihydroxy-5β-pregnan-11-one. The following compounds have not previously been found in the urine of patients with steroid 21-hydroxylase deficiency but were found in the present subjects: 5-androstene-3β, 17β-diol, 5α-pregnane-3β, 20α-diol and 3β,17α-dihydroxy-5β-pregnan-20-one. The pattern of the plasma and urinary steroids determined clearly differentiates the subjects with a steroid 21-hydroxylase defect from normal subjects and from patients with a 3β-hydroxysteroid dehydrogenase deficiency. |
| |
Keywords: | 3α-hydroxy-5α-androstan-17-one etiocholanolone 3α-hydroxy-5β-androstan-17-one epiandrosterone 3β-hydroxy-5α-androstan-17-one dehydroepiandrosterone 3β-hydroxy-5-androsten-17-one 11-ketoetiocholanolone 3αhydroxy-5β-androstane-11, 17-dione 11β-hydroxyandrosterone 3α, 11 β-dihydroxy-5α-androstan-17-one 16α-hydroxy androsterone 3α, 16α-dihydroxy-5α-androstan-17-one 18-hydroxyandrosterone 3α,18-dihydroxy-5α-androstan-17-one 7α-hydroxydehydroepiandrosterone 3β,7α-dihydroxy-5-androsten-17-one 7β-hydroxydehydroepiandrosterone 3β,7β-dihydroxy-5-androsten-17-one pregnenolone 3β-hydroxy-5-pregnen-20-one progesterone 4-pregnene-3, 20-dione 17α-hydroxyprogesterone 17α-hydroxy-4-pregnene-3.20-dione cortisol 11β, 17α, 21-trihydroxy-4-pregnene-3,20-dione 9α-fluorocortisol 9α-fluoro-11β,17α,21-trihydroxy-4-pregnene-3,20-dione dexamethasone 9α-fluoro-16α-methyl-11β, 17α, 21-trihydroxy-i,4-pregnadiene-3,20-dione |
本文献已被 ScienceDirect 等数据库收录! |
|